NEK2 and liver cancer: Preparing an anti-NEK2 monoclonal antibody (mAb) and using an mAb to establish an enzyme-linked immunosorbent assay (ELISA) kit can be applied in the detection of liver cancer in the population and improve the detection rate of liver cancer, especially in high-risk populations.